Tran-Duy, A. ., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., … de Boer, A. . (2018). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
A. de Boer
First name
A.
Last name
de Boer
Ahmadizar, F. ., Souverein, P. ., de Boer, A. ., & van der Zee, A. H. M.-. (2018). Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13482
Oshagbemi, O. A., Keene, S. J., Driessen, J. H. M., Jordan, R. ., Wouters, E. F. M., de Boer, A. ., … Franssen, F. M. E. (2018). Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013. Respir Med. http://doi.org/10.1016/j.rmed.2018.09.010
Mahmoudpour, S. H., Asselbergs, F. W., Souverein, P. C., de Boer, A. ., & van der Zee, A. H. M.-. (2018). Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13692
Tran-Duy, A. ., Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., … de Boer, A. . (2019). Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study. J Intern Med. http://doi.org/10.1111/joim.12826
Lefeber, G. J., Koek, H. L., Souverein, P. C., Bouvy, M. L., de Boer, A. ., & Knol, W. . (2019). Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database. J Am Geriatr Soc. http://doi.org/10.1111/jgs.16227
Gieling, E. ., de Vries, F. ., Williams, R. ., van Onzenoort, H. A. W., de Boer, A. ., Cate, T. ., … Burden, A. . (2019). Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists. Int J Clin Pharm. http://doi.org/10.1007/s11096-019-00916-1
Oshagbemi, O. A., Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. M.-., Driessen, J. H. M., de Boer, A. ., & de Vries, F. . (2019). C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD. Pulm Pharmacol Ther. http://doi.org/10.1016/j.pupt.2019.101870
Althunian, T. A., de Boer, A. ., Groenwold, R. H. H., Rengerink, K. O., Souverein, P. C., & Klungel, O. H. (2020). Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5065
Zhang, Y. ., Souverein, P. C., Gardarsdottir, H. ., van den Ham, H. A., van der Zee, A. H. M.-., & de Boer, A. . (2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14227